This anti-CEACAM8 antibody is a Mouse Monoclonal antibody detecting CEACAM8 in FACS and FM. Suitable for Human. This Primary Antibody has been cited in 1 publication.
Reacts with CD66b, a glycosylphosphatidylinositol (GPI) linked protein with a molecular weight of 100 kD expressed on granulocytes. This molecule was previously clustered as CD67 in the Fourth Human Leucocyte Differentiation Antigen (HLDA) Workshop and renamed CD66b in the Fifth HLDA Workshop. CD66b is a member of the carcinoembryonic antigen (CEA)-like glycoprotein family present on granulocytes and referred to as non-specific cross-reacting antigens (NCA). Granulocyte activation induced with soluble stimulators (calcium ionophore, phorbol myristate acetate, Nformylmethionyl- leucyl-phenylalanine) results in release and increased expression of NCA. Findings suggest that these molecules may play a role in phagocytosis, chemotaxis and adherence. Profile of peripheral blood lymphocytes analyzed on a FACScan